Seres Therapeutics (MCRB) Income from Discontinued Operations (2023 - 2024)
Seres Therapeutics' (MCRB) quarterly Income from Discontinued Operations came in at $139.8 million in Q3 2024, up 2144.32% year-over-year from $6.2 million in Q4 2023, and up 2194.86% quarter-over-quarter from -$6.7 million in Q2 2024.
Powered by 
Analysis
Seres Therapeutics (MCRB) Income from Discontinued Operations (2023 - 2024) Analysis & Trends
Seres Therapeutics has disclosed Income from Discontinued Operations across 2 years of filings, most recently posting $139.8 million for Q3 2024.
- In Q3 2024, Income from Discontinued Operations rose 2144.32% year-over-year to $139.8 million; the TTM figure through Jun 2025 stood at $139.8 million (up 612.62% YoY), while the FY2024 annual figure was $125.9 million, up 64.79% from the prior year.
- Income from Discontinued Operations came in at $139.8 million for Q3 2024 at Seres Therapeutics, up from -$6.7 million in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of $139.8 million in Q3 2024 to a low of -$7.2 million in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.85 Bn | 192.86 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.09 Bn | 176.91 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.06 Bn | 123.21 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.82 Bn | 73.82 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.39 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.31 Bn | 49.17 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.13 Bn | 29.82 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.23 Bn | 29.23 Bn | 1.16 Mn | - |
| 10 | Seres Therapeutics | 49.89 Mn | 49.89 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 139.81 Mn |
| Jun 30, 2024 | -6.67 Mn |
| Mar 31, 2024 | -7.23 Mn |
| Dec 31, 2023 | -6.53 Mn |
| Sep 30, 2023 | -6.84 Mn |